 |
 |
| With little variation in the scientific market, Newport's overall sales have tended to swing with the semiconductor sector historically. But the addition of High Q and Ophir, and continued growth in life and health sciences, the company will be less exposed to the current semiconductor downturn. Data source: Newport Q3 2011 supplemental information. |
| © 2024 SPIE Europe |
|
